0001209191-22-058608.txt : 20221123 0001209191-22-058608.hdr.sgml : 20221123 20221123160535 ACCESSION NUMBER: 0001209191-22-058608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perrin Steven CENTRAL INDEX KEY: 0001824545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 221416365 MAIL ADDRESS: STREET 1: C/O ANELIXIS THERAPEUTICS, INC. STREET 2: 1500 DISTRICT AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-23 0 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001824545 Perrin Steven C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD STE. 550 IRVINE CA 92612 1 1 0 0 President Common Stock 2022-11-23 4 P 0 1000 2.5969 A 1000 D This Form 4 reports an open market purchase by the Reporting Person of shares of common stock in accordance with the Issuer's trading policies. /s/ Steve Perrin 2022-11-23